Factors determining whether diffuse large B-cell lymphoma samples are detected by flow cytometry

Flow cytometry (FCM) is widely used in the diagnosis of mature B-cell neoplasms (MBN), and FCM data are usually consistent with morphological findings. However, diffuse large B-cell lymphoma (DLBCL), a common MBN, is sometimes not detected by FCM. This study aimed to explore factors that increase th...

Full description

Saved in:
Bibliographic Details
Published in:International journal of laboratory hematology 2023-12, Vol.45 (6), p.927-934
Main Authors: Peng, David, Kodituwakku, Aruna, Le, Steven, Smith, Sandy A B C, Qiu, Min R, Earls, Peter, Field, Andrew S, Parker, Andrew J C, Law, Matthew, Milliken, Samuel T, Sewell, William A
Format: Article
Language:English
Subjects:
Biopsy
Diagnosis
Fibrosis
Flow cytometry
Germinal centers
Immunohistochemistry
Lymphocytes T
Lymphoma
Myc protein
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Flow cytometry (FCM) is widely used in the diagnosis of mature B-cell neoplasms (MBN), and FCM data are usually consistent with morphological findings. However, diffuse large B-cell lymphoma (DLBCL), a common MBN, is sometimes not detected by FCM. This study aimed to explore factors that increase the likelihood of failure to detect DLBCL by FCM. Cases with a final diagnosis of DLBCL that were analysed by eight-colour FCM were retrospectively collated. Clinical, FCM, histopathological and genetic data were compared between cases detected and cases not detected by FCM. DLBCL cases from 135 different patients were analysed, of which 22 (16%) were not detected by FCM. In samples not detected by flow cytometry, lymphocytes were a lower percentage of total events (p = 0.02), and T cells were a higher percentage of total lymphocytes (p = 0.01). Cases with high MYC protein expression on immunohistochemistry were less likely to be missed by FCM (p = 0.011). Detection of DLBCL was not different between germinal centre B-cell (GCB) and non-GCB subtypes, not significantly affected by the presence of necrosis or fibrosis, and not significantly different between biopsy specimens compared to fine-needle aspirates, or between samples from nodal compared to extranodal tissue. The study identifies several factors which affect the likelihood of DLBCL being missed by FCM. Even with eight-colour analysis, FCM fails to detect numerous cases of DLBCL.
ISSN:1751-5521
1751-553X
DOI:10.1111/ijlh.14158